Eli Lilly CEO Dave Ricks publicly rebutted Anthropic CEO Dario Amodei's prediction that AI will cure cancer within a decade, calling the vision appealing but unlikely. He argued that major gaps remain in biological understanding and that randomized human trials, not drug discovery speed, are the real bottleneck, so AI will likely deliver steady incremental progress rather than a sudden breakthrough.
Eli Lilly
礼来
US multinational pharmaceutical company spanning cardiometabolic, oncology, immunology and neuroscience, a leading player in dia
Curated Intelligence
IT之家 · 智能时代T2·Industry
58 pts
Hacker News AIT2·Industry
58 pts
Eli Lilly's CEO publicly pushed back on Anthropic CEO Dario Amodei's prediction that cancer, Alzheimer's, heart disease and mental illness will be cured within a decade, calling the timeline medically unrealistic. The dispute unfolded around Anthropic's IPO launch, with experts widely criticizing the overpromise as Theranos-style hype.